There are several reasons for the disparity. The Canadian system takes advantage of centralized buying by the provincial governments that have more market heft and buy in bulk, lowering prices. By contrast, the U.S. has explicit laws that prohibit Medicare or Medicaid from negotiating drug prices. In addition, price negotiations by Canadian health insurers are based on evaluations of the clinical effectiveness of prescription drugs,[89] allowing the relative prices of therapeutically-similar drugs to be considered in context. The Canadian Patented Medicine Prices Review Board also has the authority to set a fair and reasonable price on patented products, either comparing it to similar drugs already on the market, or by taking the average price in seven developed nations.[90][91] Prices are also lowered through more limited patent protection in Canada. In the U.S., a drug patent may be extended five years to make up for time lost in development.[92] Some generic drugs are thus available on Canadian shelves sooner.[93]The pharmaceutical industry is important in both countries, though both are net importers of drugs. Both countries spend about the same amount of their GDP on pharmaceutical research, about 0.1% annually[94]
Dear Anna,Thank you for contacting drugstore.com regarding the pricing of medication.The $129.99 is within a small percentage of the price we pay for the medication [wholesale]. Since we are a mail order pharmacy, we do not have the overhead costs that may be added on to the price at other pharmacies.
Amgen, the maker of Aranesp (EPO), probably the most important drug we take, and fabulously better than the constant blood transfusions that were needed before the erythropoiesis-stimulating agent was invented, has been quite profitable. One might say fabulously profitable as it was the basis for the creation of a giant corporation with 17,000 employees and $14.6 Billion in sales and $4.6 Billion in Profits in 2009. It is certainly a matter of opinion, but I for one, am happy that they exist, and am happy that they continue making a profit and seeking to invent new fabulously expensive drugs. Without the incentive to become fabulously wealthy it is highly unlikely that the drug would exist. Someday EPO will be very cheap. Patients won't bitch about Angen then, eh?
As for the "pissing contest" (hahahaha a pissing contest on a dialysis support board....) Let's just stop right now, take a deep breath and remember that these are people at the other end of the keyboard. My advice is do not type anything that you wouldn't say to someone's face.
A new study published in the Journal of the American Medical Association has concluded that patients in for-profit dialysis chains routinely get higher doses of the antianemia drug Epogen. These larger doses, while lucrative for the chains, can sometimes boost red blood cells above FDA levels. Part of the reason for the higher doses is financial. Medicare reimbursement encourages use of the drug, and clinics take in about 25 percent of their revenue through Epogen payments. What's more, drug maker Amgen offers volume discounts, which also encourages overuse. Another, more troubling reason for the large doses is that kidney specialists often hand off Epogen dosing decisions to dialysis clinic staffers, which means that doses aren't calibrated to individual needs. Meanwhile, the FDA is concerned enough about Epogen--and other erythropoietin drugs--that it placed its most severe warning on all of them.Read more: Study: Dialysis chains profit from higher Epogen use - FierceHealthcare http://www.fiercehealthcare.com/story/study-dialysis-chains-profit-from-higher-epogen-use/2007-04-18#ixzz0qPCg3AsD
I'll trust you'll show me the very basic courtesy of not applying it to my actions. Comparing the use of that phrasing to 'I hate dialysis' is ludicrous. Dialysis is a machine and process, not a person, and there is no vulgarity in that sentence. I apologize. I didn't intend the word in any pejorative manner. The usage of the word as a verb/adverb is in a state of flux in modern culture and isn't considered offensive by everybody. I will be more careeful in the future. again sorry, noharm intended. respectfully..Sid
>>> < 6/21/2010 9:46 PM >>>What about doctors visits, hospitalizations and blood work? Will those be covered?Thanks,Anna Bennett-----Original Message-----From: To: Sent: Tue, Jun 22, 2010 3:14 pmSubject: Re: Ask Congress to Continue to Support Immunosuppresive Drug CoverageThe legislation would extend only the immuno drugs covered under Medicare Part B (no other drugs would be extended beyond the current 3 years after the transplant). We know the follow up tests and other expenses are often a challenge, but this should be alleviated with the expanded health care coverage that will be implemented over the next few years. Troy ZimmermanVice President for Government RelationsNational Kidney Foundationwww.kidney.org/takeactionMy reply today:Has anyone asked why these drugs are so expensive in the first place? Forget about R&D etc, that is standard in a start up. But now we are in the generic phase, and these drugs are all over the map when it comes to retail pricing. Does the NKF check to see if there is gouging going on either at the manufacturer or pharmacy level? Since CMS will not negotiate their buying, are we supporting our tax dollars paying retail? And saddling people with transplants with a 100 dollar premium that will cover two expensive drugs (the majority of tx being now treated with generic Prograf and Cellcept), while valcyte (imperative in CMV control) will be out of pocket at $35.00 per pill (non generic) as well as other medications for people who have co-morbidities (the majority of transplant recipients). Under this bill, Cipro won't even be covered.I am starting to think that this lobby is simply guaranteeing payment for big pharma.Troy, am I far off in this? Please feel free to reassure me if I am.Best,Anna Bennett
You know, I sometimes wonder if I should be left alone with internet access....